HB 1418: Drug Price Transparency

HB 1418: Drug Price Transparency

Relative to Transparency and Cost Control Of Pharmaceutical Drug Prices.

New Futures supports this bill, as it allows the NH Insurance Department to collect certain information from pharmaceutical drug manufacturers that relate to the price setting of the drugs. Increases in pharmaceutical drug prices are one of the leading reasons for health insurance premium increases. Due to these rising costs, people resort to rationing medication and making choices between buying their medications or paying bills. New Futures supports this bill because it would shine a light on the costs of drugs so that the state and, in turn, the public can better understand the increasing costs of pharmaceuticals.

Click here for bill text.

Bill Status
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote
  • Committee
  • Public Hearing
  • Executive Session
  • Full Body Vote